← TrialMatch
HomeTrials

Digital Solution for Salutogenic Brain Health (DiSaB): A Pilot Protocol for Clinical Imple

The goal of this clinical trial is to develop and learn if a digitally delivered brain health intervention (DiSaB) can help improve cognitive, physical and psychosocial health in middle-aged adults with chronic conditions at-risk for cognitive decline. The clinical trial also aims to find out the push and pull factors

Condition(s)Chronic Condition
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThe goal of this clinical trial is to develop and learn if a digitally delivered brain health intervention (DiSaB) can help improve cognitive, physical and psychosocial health in middle-aged adults with chronic conditions at-risk for cognitive decline. The clinical trial also aims to find out the push and pull factors of implementing the intervention in primary care settings. The main questions it aims to answer are: 1. Does the DiSaB intervention improve participants' cognitive functions, health measures, and psychosocial health? 2. Is an individualised or group-based health education session better at improving cognitive, physical and psychosocial health in participants who did not respond to the DiSaB intervention? 3. How useful and practical is the DiSaB intervention, according to 1. p
Who can participateInclusion Criteria: * Aged 40 - 55 years old * Have hypertension, hyperlipidaemia and/or type-2 diabetes * Ability to provide written informed consent * Posses sufficient English language skills in reading, writing and speaking * Multimorbidity conditions are also acceptable with the exception of life-threatening co-morbidities with life expectancy of less than one year * Total Risk Score (TRS) for cognitive impairment of at least 3 Exclusion Criteria: * Physical, visual and/or hearing impairment * Language impairment (i.e. severe dysarthria or aphasia) * Not within age range listed * Major or active psychiatric conditions * Diagnosis of dementia * Do not own a mobile device capable of downloading applications (i.e. Zoom), and/or do not have access to internet connection
Ages40 Years to 64 Years
SexAll
Lead sponsorNational University of Singapore
LocationsSingapore, Singapore
Start date2025-04-02
NCT IDNCT06582316
Official listinghttps://clinicaltrials.gov/study/NCT06582316

🔍 Search all trials →